Works matching DE "OVERALL survival"

Results: 5000
    1
    2
    3

    Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 456, doi. 10.1159/000541018
    By:
    • Persano, Mara;
    • Casadei-Gardini, Andrea;
    • Tada, Toshifumi;
    • Suda, Goki;
    • Shimose, Shigeo;
    • Kudo, Masatoshi;
    • Rossari, Federico;
    • Yoo, Changhoon;
    • Cheon, Jaekyung;
    • Finkelmeier, Fabian;
    • Lim, Ho Yeong;
    • Presa, José;
    • Masi, Gianluca;
    • Bergamo, Francesca;
    • Amadeo, Elisabeth;
    • Vitiello, Francesco;
    • Kumada, Takashi;
    • Sakamoto, Naoya;
    • Iwamoto, Hideki;
    • Aoki, Tomoko
    Publication type:
    Article
    4
    5
    6

    Prognostic implications of risk definitions from the monarchE and NATALEE trials Open Access.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 6, p. 1198, doi. 10.1093/jnci/djaf031
    By:
    • Arecco, Luca;
    • Blondeaux, Eva;
    • Bruzzone, Marco;
    • Arpino, Grazia;
    • Angelis, Carmine De;
    • Laurentiis, Michelino De;
    • Caputo, Roberta;
    • Fabi, Alessandra;
    • Sanna, Valeria;
    • Gori, Stefania;
    • Puglisi, Fabio;
    • Boni, Luca;
    • Nardin, Simone;
    • Giannubilo, Irene;
    • Perachino, Marta;
    • Borea, Roberto;
    • Agostinetto, Elisa;
    • Azambuja, Evandro de;
    • Lambertini, Matteo;
    • Mastro, Lucia Del
    Publication type:
    Article
    7
    8
    9

    Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients.

    Published in:
    Rheumatology, 2025, v. 64, n. 5, p. 2970, doi. 10.1093/rheumatology/keae629
    By:
    • Teboul, Alexandre;
    • Allenbach, Yves;
    • Tubach, Florence;
    • Belin, Lisa;
    • Cassius, Charles;
    • Demortier, Juliette;
    • Dossier, Antoine;
    • Faucon, Caroline;
    • Kasser, Camille;
    • Mekinian, Arsène;
    • Monseau, Grégoire;
    • Fouchard, Maxime;
    • Chambrelan, Estel;
    • Viguier, Manuelle;
    • Kluger, Nicolas;
    • Mahévas, Thibault;
    • Bergeret, Blanche;
    • Bachmeyer, Claude;
    • Lenormand, Cédric;
    • Hotz, Claire
    Publication type:
    Article
    10
    11

    Development and validation of a transcription factor regulatory network‐based signature for individualized prognostic risk in lung adenocarcinoma.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 12, p. 2440, doi. 10.1002/ijc.35375
    By:
    • Wang, Kai;
    • Xiang, Jun;
    • Zhou, Jun;
    • Chen, Congcong;
    • Wang, Zhoufeng;
    • Qin, Na;
    • Zhu, Meng;
    • Bi, Lingfeng;
    • Gong, Linnan;
    • Yang, Liu;
    • Chen, Yingjia;
    • Xu, Xianfeng;
    • Dai, Juncheng;
    • Ma, Hongxia;
    • Hu, Zhibin;
    • Li, Weimin;
    • Wang, Cheng;
    • Jin, Guangfu;
    • Shen, Hongbing
    Publication type:
    Article
    12

    Molecular patterns and mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59409-7
    By:
    • Zamuner, Fernando T.;
    • Gunti, Sreenivasulu;
    • Starrett, Gabriel J.;
    • Faraji, Farhoud;
    • Toni, Tiffany;
    • Saraswathula, Anirudh;
    • Vu, Kenny;
    • Gupta, Anuj;
    • Zhang, Yan;
    • Faden, Daniel L.;
    • Bryan, Michael E.;
    • Guo, Theresa;
    • Rowan, Nicholas R.;
    • Ramanathan Jr., Murugappan;
    • Lane, Andrew P.;
    • Fakhry, Carole;
    • Gallia, Gary L.;
    • Allen, Clint T.;
    • Rooper, Lisa M.;
    • London Jr., Nyall R.
    Publication type:
    Article
    13

    Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.

    Published in:
    Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02376-w
    By:
    • Meng, Xiangrui;
    • Yang, Xiuli;
    • Hong, Yonggui;
    • Wang, Wenkang;
    • Zhang, Zhiye;
    • Xia, Jin;
    • Chen, Yunfang;
    • Zhou, Yue;
    • Lu, Taiying;
    • Song, Min;
    • Shan, Zhengzheng;
    • Wu, Tao;
    • Wu, Weilong;
    • Shen, Ling;
    • Guan, Lulu;
    • Ma, Mingying;
    • Wang, Lisen;
    • Luo, Xi;
    • Xin, Dao;
    • Ma, Yihui
    Publication type:
    Article
    14
    15
    16
    17

    Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 6, p. 1020, doi. 10.1111/ejh.14410
    By:
    • Abuhelwa, Ahmad Y.;
    • Almansour, Sara A.;
    • Basch, Ethan;
    • Al‐Shamsi, Humaid O.;
    • Abuhelwa, Ziad;
    • Bustanji, Yasser;
    • Semreen, Mohammad H.;
    • Kharaba, Zelal;
    • Ali, Salma M.;
    • Mohamed, Rawan;
    • Kichenadasse, Ganessan;
    • McKinnon, Ross A.;
    • Sorich, Michael J.;
    • Alzoubi, Karem H.;
    • Hopkins, Ashley M.
    Publication type:
    Article
    18
    19

    Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy.

    Published in:
    European Journal of Clinical Nutrition, 2025, v. 79, n. 6, p. 576, doi. 10.1038/s41430-025-01566-5
    By:
    • Perrier, Marine;
    • Fontaine, Marine;
    • Bertin, Eric;
    • Carlier, Claire;
    • Botsen, Damien;
    • Djelouah, Manel;
    • François, Eric;
    • Guilbert, Philippe;
    • Saint, Angélique;
    • Slimano, Florian;
    • Torielli, Paolo;
    • Brugel, Mathias;
    • Bouché, Olivier
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real‐World Multicenter Study.

    Published in:
    International Journal of Urology, 2025, v. 32, n. 6, p. 679, doi. 10.1111/iju.70030
    By:
    • Ozaki, Kai;
    • Yamamoto, Hayato;
    • Sekine, Yuya;
    • Horiguchi, Hirotaka;
    • Hosogoe, Shogo;
    • Mikami, Jotaro;
    • Fujita, Naoki;
    • Tokui, Noriko;
    • Okita, Kazutaka;
    • Okamoto, Teppei;
    • Mori, Kanami;
    • Kobayashi, Mizuki;
    • Numakura, Kazuyuki;
    • Yoneyama, Takahiro;
    • Tabata, Ryuji;
    • Sato, Satoshi;
    • Habuchi, Tomonori;
    • Ohyama, Chikara;
    • Hatakeyama, Shingo
    Publication type:
    Article
    50